The global hemostasis & tissue sealing agents market is expected to register a substantial CAGR during the forecast period, between 2021 and 2028. Hemostasis is defined as the process of healing wounds by blood coagulation. Coagulation is defined as the initial phase in the wound healing process or a complex physiological process where soluble and insoluble proteins converts blood from its original liquid form to a gel form. During surgery, it is critical to control the patient's excessive bleeding in order to avoid further harm or death due to blood loss. Hemostats and sealants are medical devices that are used to stop bleeding and hemorrhage caused by injuries or surgical operations.
Market Trends, Drivers, Restraints, and Opportunities
- Increased demand for minimally invasive procedures and technological advancements are estimated to fuel the market growth.
- FDA has approved a number of hemostatic products, which can fuel the expansion of the market.
- Increase in the geriatric population and the prevalence of chronic illnesses are major drivers that can boost the market growth.
- Growing number of surgical procedures is boosting the market growth.
- High product pricing and stringent environment regulations can hinder the future growth.
- Rise in the incidence of minor burn injuries and neurosurgical management is also estimated to offer market opportunities for hemostats in the coming years.
Scope of the Hemostasis & Tissue Sealing Agents Market Report
The report on hemostasis & tissue sealing agents market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Hemostasis & Tissue Sealing Agents Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018 & 2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Product Types (Adhesive & Tissue Sealing Agents [Adhesion Barrier Products, Natural Tissue Sealants, and Synthetic Tissue Sealants], and Topical Hemostats [Active Hemostats, Fibrin Sealants, Flowable Hemostats, Mechanical Hemostats, and Topical Thrombin Products]), Applications (Minimally invasive Surgery, General surgery, and Others), End-users (Ambulatory surgical centres, Hospitals, and Others),
|
|
Regional Scope
|
Asia Pacific, North America, Europe, Latin America, and Middle East & Africa
|
|
Report Coverage
|
Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast
|
|
Key Players Covered in the Report
|
Advanced Medical Solutions Group Plc, Becton, Dickinson & Company, Cryolife, Inc., Pfizer, Inc., Baxter International, Inc., Johnson & Johnson, Braun Melsungen AG, Medtronic plc, Entegrion, Inc., and MIL Laboratories Pvt. Ltd.
|
Hemostasis & Tissue Sealing Agents Market Segment Insights
Topical hemostats segment is projected to hold a significant market share
Based on product types, the market can be bifurcated into adhesive & tissue sealing agents and topical hemostats. The adhesive & tissue sealing agents segment can be further segmented into adhesion barrier products, natural tissue sealants, and synthetic tissue sealants. Furthermore, the topical hemostats segment can be classified as active hemostats, fibrin sealants, flowable hemostats, mechanical hemostats, and topical thrombin products. The topical hemostats segment is projected to hold a significant market share. When ligatures or traditional techniques are unsuccessful or impracticable, topical hemostats serve as a vital role in controlling bleeding during surgical procedures.
Topical hemostats are typically used in conjunction with conventional treatment to provide cost-effectiveness, quick and easy absorption of the hemostatic substance and leads to minimum tissue reactivity. These medications prevent post-operative problems following surgical operations by diffusing bone haemorrhage, venous bleeding, and surface bleeding. Such elements contribute to the expansion of this segment during the forecast period.
Minimally invasive surgery segment is anticipated to account for a substantial share
On the basis of applications, the market can be segregated into minimally invasive surgery, general surgery, and others. The minimally invasive surgery segment is anticipated to account for a substantial share due to fewer medical constraints and hazards connected during the surgery. Furthermore, a faster recovery time leads to a shorter hospital stay, which can promote demand for these minimally invasive procedures, fueling the segmental development.
Hospitals segment to expand at a substantial growth rate during the forecast period
In terms of end-users, the hemostasis & tissue sealing agents market can be fragmented into ambulatory surgical centers, hospitals, and others. The hospitals segment is estimated to expand at a substantial growth rate during the forecast period. Hospitals provide high-quality minimally invasive surgical procedures at a reasonable cost. Moreover, increasing application of hemostats products for the prevention of blood loss in various conventional as well as less invasive operations is one of the primary development propelling factors. Furthermore, increasing population preference for hospitals over other medical settings due to price and availability of essential medical amenities is fostering the market segment growth.
North America is expected to dominate the market
In terms of regions, the market can be categorized as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to dominate the market. The availability of competent experts, technical developments, rising acceptance of hemostats products for treatment of various bleeding diseases, and the existence of major market players in the area are likely to drive significant growth in the US during the forecast period. Furthermore, growing healthcare costs as well as an increase in the number of sports-related injuries, are major factors driving the regional growth.
Segments
By Product Types
- Adhesive & Tissue Sealing Agents
- Adhesion Barrier Products
- Natural Tissue Sealants
- Synthetic Tissue Sealants
- Topical Hemostats
- Active Hemostats
- Fibrin Sealants
- Flowable Hemostats
- Mechanical Hemostats
- Topical Thrombin Products
By Applications
- Minimally invasive surgery
- General surgery
- Others
By End-users
- Ambulatory surgical Centers
- Hospitals
- Others
By Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
By Key Players
Competitive Landscape
Key players in the Hemostasis & Tissue Sealing Agents market are Advanced Medical Solutions Group Plc, Becton, Dickinson & Company, Cryolife, Inc., Pfizer, Inc., Baxter International, Inc., Johnson & Johnson, Braun Melsungen AG, Medtronic plc, Entegrion, Inc., and MIL Laboratories Pvt. Ltd. These players are constantly engaged in several market development strategies including collaborations, agreements, mergers & acquisitions, production capacity expansion, new product launches, and partnerships to increase their market share.
Request For Customization
Enquiry Before Buying
Speak With Analyst
